The magic of the movies - molecules in 4D

July 16, 2012
The research team pictured in front of supercomputer, Orchard: (l to r) Dr Itamar Kass, Cyril Reboul, Associate Professor Ashley Buckle and Ben Porebski

(Phys.org) -- Computer simulations of how the body's tiniest building blocks behave are helping scientists to unlock the role of molecules in human diseases. 

In a series of recent studies, researchers from Monash University's School of Biomedical Sciences have shown how important the movements and interactions of are to how the body develops disease, and detects and responds to it.

Associate Professor Ashley Buckle, who led the three projects said his team's simulations, which can take months to perform on a supercomputer, were revealing the molecular ‘choreography’ of proteins that is impossible to detect using purely experimental techniques. 

"Researchers in our field have traditionally used X-ray crystallography to take a snap shot of the structure of a molecule," Associate Professor Buckle said.

"There are a number of transient interactions between molecules that we will never see using experimental techniques. These interactions explain a lot about how proteins behave and what happens when they misbehave.  We need to extrapolate from the experimental data - the snapshots - and recreate the movements of molecules to explore this."

The video will load shortly
Conformational flexibility of peptide in HLA-B*3501-LPEP and HLA-B*3508-LPEP during MD simulations. The polymorphic (R/L156) residue is shown in green. Static snapshots of the respective simulations are shown in the insets.

Three recent publications demonstrate the importance of this emerging research technique. Research published in PLoS Computational Biology details the key role of movement of immune system proteins in recognising infections and triggering an immune response.

"That recognition is a key event and, previously, we didn't fully understand how it happened. Simulating how the molecules move had added an extra dimension to our understanding," Associate Professor Buckle said.

A second paper, also in PLoS Computational Biology explains why an enzyme that could be an important antibiotic target works effectively when locked firmly into a group of four, but not in a “wobbly” pair. Understanding this structure could help develop treatments for an antibiotic-resistant superbug called MRSA.

A third paper, published in Biophysical Journal explains a protein mutation that causes cirrhosis of the liver.

"Using X-ray crystallography, the normal protein and the mutant protein look exactly the same. When we ran the , we could see important differences in the way the molecules moved, that could explain why the mutant protein misbehaves and causes disease," Associate Professor Buckle said.

The simulations have proven so valuable that the team has set up their own supercomputer facility at Monash, known as “Orchard”, which has allowed their research to progress much faster.

"Having our own 800-core supercomputer means we can have simulations running 24/7. These simulations are so incredibly difficult that it takes months to produce a movie representing a fraction of a microsecond in real-time," Associate Professor Buckle said.

"If we were using a shared facility, the simulations that we've been running for two years would be nowhere near complete by now."

View some of the simulations at the groups' research page.

Explore further: Supercomputer reveals new details behind drug-processing protein model

Related Stories

Untangling a protein's influences

January 6, 2012

Most proteins have multiple moving parts that rearrange into different conformations to execute particular functions. Such changes may be induced by molecules in the immediate environment, including water and similar solvents ...

'Fingerprints' match simulations with reality

March 22, 2011

A theoretical technique developed at DOE's Oak Ridge National Laboratory is bringing supercomputer simulations and experimental results closer together by identifying common "fingerprints."

Disarming disease-causing bacteria

April 4, 2012

(PhysOrg.com) -- New treatments that combat the growing problem of antibiotic resistance by disarming rather than killing bacteria may be on the horizon, according to a new study. 

Recommended for you

Canada conservationist warns of 'cyber poaching'

February 25, 2017

Photographers, poachers and eco-tour operators are in the crosshairs of a Canadian conservationist who warns that tracking tags are being hacked and misused to harass and hunt endangered animals.

How proteins reshape cell membranes

February 24, 2017

Small "bubbles" frequently form on membranes of cells and are taken up into their interior. The process involves EHD proteins - a focus of research by Prof. Oliver Daumke of the MDC. He and his team have now shed light on ...

Neanderthal DNA contributes to human gene expression

February 23, 2017

The last Neanderthal died 40,000 years ago, but much of their genome lives on, in bits and pieces, through modern humans. The impact of Neanderthals' genetic contribution has been uncertain: Do these snippets affect our genome's ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.